ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0RPS Medicover Ab

81.20
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medicover Ab LSE:0RPS London Ordinary Share SE0009778848 MEDICOVER ORD SHS CLASS B
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 81.20 79.20 83.20 682 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 1.75B 17.6M 0.2412 336.65 5.93B

Medicover acquires CDT Medicus Group in Poland

05/11/2021 7:11am

PR Newswire (US)


Medicover Ab (LSE:0RPS)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Medicover Ab Charts.

STOCKHOLM, Nov. 5, 2021 /PRNewswire/ -- Medicover has signed an agreement to acquire CDT Medicus Group (CDT), a leading regional provider of medical services operating in the South Western Polish region of Legnicko-Glogowski Okreg Miedziowy (LGOM). The transaction is subject to customary merger control approvals and closing is expected in early 2022.

CDT was established in 1992 and operates two hospitals, 13 outpatient clinics (mainly focused on primary care), three diagnostic laboratories, and is lead by an experienced management team with 1,000 employees. CDT operations are financed with around 60% NHF financed outpatient and inpatient services, 35% Fee-For-Service, and the balance being corporate contracts or insurer paid. The LGOM region is a densely populated area with proximity to over 500,000 people.

Medicover acquires 100 per cent of the voting rights for 54 MEUR including assumed debt. The transaction value implies a low double-digit EBITDA multiple, excluding synergies. Revenue for 2020 amounted to 22 MEUR. The acquisition will be funded with current committed debt facilities and will be accretive in 2022. Synergies are expected to be realised over 2022 and subsequently as the operations are integrated to Medicover's other Polish operations.

"With this acquisition we are strengthening our offering in the Healthcare Services division and in the LGOM catchment area with good quality healthcare and a foundation to further growth. I'm pleased to welcome CDT Medicus Group and its employees to the Medicover family", says Fredrik Rågmark, CEO.  

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com

The information was provided for publication by the abovementioned contact person at 08.00 CET on 5 November 2021.

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of EUR 998 million and more than 32,000 employees. For more information, go to www.medicover.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/medicover/r/medicover-acquires-cdt-medicus-group-in-poland,c3447751

The following files are available for download:

https://mb.cision.com/Main/15662/3447751/1491816.pdf

Medicover aquires CDT Medicus Group in Poland

 

Copyright 2021 PR Newswire

1 Year Medicover Ab Chart

1 Year Medicover Ab Chart

1 Month Medicover Ab Chart

1 Month Medicover Ab Chart

Your Recent History

Delayed Upgrade Clock